New hope in cheap steroid

Low doses of the steroid dexamethasone can reduce deaths by one-third in severely affected COVID-19 patients, according to researchers who assessed the performance of the inexpensive drug in more than 2,100 people.

The analysis is part of the RECOVERY (Randomised Evaluation of COVid-19 thERapY) trial which was established to test a range of potential therapies for COVID-19, including low-dose dexamethasone – a cheap steroid treatment.

The RECOVERY trial included over 11,500 patients, enrolled from more than 175 hospitals in the UK, noted a statement published by the University of Oxford on Tuesday.

Leave a Reply

Your email address will not be published. Required fields are marked *